FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention relates to the field of pharmaceutics and medicine and application of 4-methyl-3-[[4-(3-pyrinidyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazole-1-yl)-3-(trifluoromethyl)phenyl]benzamide to produce pharmaceutical composition for treatment of disease dependent on activity of protein kinase.
EFFECT: production of pharmaceutical composition for treatment of disease dependent on activity of protein kinase, first of all, pulmonary hypertension.
2 cl, 1 ex
Authors
Dates
2010-11-27—Published
2006-01-26—Filed